Cryoablation of atypical atrioventricular nodal reentry tachycardia
- PMID: 34535930
- DOI: 10.1111/jce.15244
Cryoablation of atypical atrioventricular nodal reentry tachycardia
Abstract
Aim: Data on ablation for atypical recurrent atrioventricular nodal reentry tachycardia (AVNRT) and long-term follow-up are generally sparse. Furthermore, the rate of recurrence and safety of cryoablation for atypical AVNRT has not been established. We compared patients cryoablated for atypical AVNRT and typical AVNRT during long-term follow-up.
Methods: All patients (n = 2612) who underwent catheter ablation for AVNRT at the Karolinska University Hospital between January 2009 and August 2019 were analyzed. A total of 91 patients undergoing first-time cryoablation for atypical AVNRT were included. A control group with first-time cryoablation for typical AVNRT was matched in a 1:1 ratio. Patients were followed-up for recurrences for a median of 5.0 years (interquartile range: 3.1-7.5 years).
Results: After 5 years, AVNRT recurrence occurred in 10 patients (11.0%) in the atypical AVNRT group and in 8 patients (8.8%) in the typical AVNRT group (hazard ratio: 1.31 [95% confidence interval: 0.52-3.32]; p = 0.568). The duration of the index procedure was significantly longer for atypical compared to typical AVNRT ablation (132.1 ± 49.2 min vs. 110.1 ± 38.8 min; p = 0.001). Transient AV blocks occurred in a similar fashion in the atypical compared to typical group (11 [12.1%] vs. 4 [4.9%]; p = 0.103). However, no ablation induced persistent AV block developed in either group.
Conclusion: Cryoablation for atypical AVNRT showed similar rate of recurrences and safety compared to typical AVNRT during long-term follow-up.
Keywords: atypical atrioventricular nodal reentry tachycardia; cardiac electrophysiology; cryoablation.
© 2021 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.
Comment in
-
Classification of AVNRT: An unresolved entity.J Cardiovasc Electrophysiol. 2022 Feb;33(2):322. doi: 10.1111/jce.15321. Epub 2021 Dec 18. J Cardiovasc Electrophysiol. 2022. PMID: 34910343 No abstract available.
-
Response to "Classification of AVNRT: An unresolved entity".J Cardiovasc Electrophysiol. 2022 Feb;33(2):323. doi: 10.1111/jce.15322. Epub 2021 Dec 21. J Cardiovasc Electrophysiol. 2022. PMID: 34935235 No abstract available.
References
REFERENCES
-
- Brugada J, Katritsis DG, Arbelo E, et al, ESC Scientific Document Group. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020;41:655-720.
-
- Farkowski MM, Pytkowski M, Maciag A, et al. Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study. Europace. 2014;16:1821-1827.
-
- Goldberg AS, Bathina MN, Mickelsen S, Nawman R, West G, Kusumoto FM. Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy). Am J Cardiol. 2002;89:1120-1123.
-
- Katritsis DG, Zografos T, Katritsis GD, et al. Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial. Europace. 2017;19:602-606.
-
- Bathina MN, Mickelsen S, Brooks C, Jaramillo J, Hepton T, Kusumoto FM. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol. 1998;82:589-593.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
